TABLE 1.
Baseline age, sex, and migraine data for migraine patients with simple or complex aura and without aura taking migraine preventive medication.
| Data | Migraine with aura (n = 48) | Migraine without aura (n = 142) |
P (with vs. without aura) |
P (simple vs. complex aura) |
||
| Overall (n = 48) |
Simple (n = 44) |
Complex (n = 4) |
||||
| Median age, years (IQR) | 36.5 (30–49) |
33.5 (30-49) |
42.0 (38.3-48) |
46.0 (36–54.3) |
0.012* | 0.42 |
| Female sex, n (%) | 40 (83.3) | 36 (81.8) | 4 (100) | 119 (83.8) | 0.94 | NA |
| Comorbidity presence, n (%) | 27 (56.3) | 24 (54.5) | 3 (75.0) | 81 (57.0) | 0.94 | 0.79 |
| Median history of migraine headache, years (IQR) | 5.0 (2.1–10) |
5.0 (2.1-10) |
10 (4-17.5) |
6.3 (2–10.5) |
0.41 | 0.34 |
| Chronic migraine subtype, n (%) | 17 (35.4) | 15 (34.1) | 2 (50.0) | 54 (38.0) | 0.75 | 0.93 |
| Chronic migraine with MOH | 5 (10.4) | 4 (9.1) | 1 (25.0) | 14 (9.9) | 0.91 | 0.89 |
| Median MMDs/MHDs (IQR) | 16.6 (8–28) |
12 (8-28) |
28 (16-28) |
14.0 (8–28) |
0.99 | 0.11 |
| Mean MMDs/MHDs | 16.6 (9.1) | 15.9 (9.0) | 24 (8.0) | 16.7 (9.0) | 0.95 | 0.09 |
| Median Thai-version MSQ v. 2.1 score (IQR) | 60.1 (47.2–72.9) |
63.6 (48.3–77.9) |
51.5 (45–57.9) |
62.9 (48.6–80.4) |
0.80 | 0.25 |
| Median Thai-version MIDAS score (IQR) | 4 (0–9.3) |
4 (0–9.3) |
3 (0–11.3) |
5.4 (0–5) |
0.16 | 0.78 |
| Number of preventive medications, n (%) ∙ Monotherapy ∙ Polytherapy |
40 (83.3) 8 (16.7) |
37 (84.1) 7 (15.9) |
3 (75.0) 1 (25.0) |
114 (80.3) 28 (19.7) |
0.77 |
0.97 |
| Migraine prevention inhibiting spreading depolarizations used, n (%) | 19 (39.6) | 19 (43.2) | 0 (0) | 51 (35.9) | 0.78 | NA |
MIDAS, migraine disability assessment questionnaire; MMDs/MHDs, monthly migraine/headache days; MOH, medication-overuse headache; MSQ, migraine-specific quality of life questionnaire.